Skip to main content
SpringerLink
Log in

Pulmonary and Critical Care Medicine

  • Chapter
  • First Online:
Geriatrics for Specialists

  • 1049 Accesses

Abstract

Over the last decade, the medical community has come to appreciate a growing number of differences in caring for older patients as compared to a younger population. This growth in knowledge includes special considerations for older patients with pulmonary disease and critical illness. This chapter will review how physiologic changes of aging alter how clinicians approach common pulmonary disease processes as well as highlight special considerations when caring for older patients with critical illness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Turner JM, Mead J, Wohl ME. Elasticity of human lungs in relation to age. J Appl Physiol. 1968;25(6):664–71.

    Article  CAS  PubMed  Google Scholar 

  2. Janssens J-P, Pache J-C, Nicod L. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999;13(1):197–205.

    Article  CAS  PubMed  Google Scholar 

  3. Fukuchi Y. The aging lung and chronic obstructive pulmonary disease: similarity and difference. Proc Am Thorac Soc. 2009;6(7):570–2.

    Article  CAS  PubMed  Google Scholar 

  4. Snider GL, et al. The definition of emphysema: report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. American Lung Association; 1985.

    Google Scholar 

  5. Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest. 2009;135(1):173–80.

    Article  PubMed  Google Scholar 

  6. Busse PJ, et al. Effect of aging on sputum inflammation and asthma control. J Allergy Clin Immunol. 2017;139(6):1808–1818. e6.

    Article  CAS  PubMed  Google Scholar 

  7. Nyenhuis SM, et al. Airway neutrophil inflammatory phenotype in older asthma subjects. J Allergy Clin Immunol. 2010;125(5):1163.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. DeMarco VG, et al. Contribution of oxidative stress to pulmonary arterial hypertension. World J Cardiol. 2010;2(10):316.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Richter K, Kietzmann T. Reactive oxygen species and fibrosis: further evidence of a significant liaison. Cell Tissue Res. 2016;365(3):591–605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Davidson WR Jr, Fee EC. Influence of aging on pulmonary hemodynamics in a population free of coronary artery disease. Am J Cardiol. 1990;65(22):1454–8.

    Article  PubMed  Google Scholar 

  11. Lam CS, et al. Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation. 2009;119(20):2663.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Tolep K, et al. Comparison of diaphragm strength between healthy adult elderly and young men. Am J Respir Crit Care Med. 1995;152(2):677–82.

    Article  CAS  PubMed  Google Scholar 

  13. Barreiro E, Gea J. Respiratory and limb muscle dysfunction in COPD. COPD: J Chron Obstruct Pulmon Dis. 2015;12(4):413–26.

    Article  Google Scholar 

  14. Ho JC, et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med. 2001;163(4):983–8.

    Article  CAS  PubMed  Google Scholar 

  15. Tuder RM. Aging and cigarette smoke: fueling the fire. American Thoracic Society; 2006.

    Google Scholar 

  16. Løkke A, et al. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935–9.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Divo MJ, et al. Chronic obstructive pulmonary disease (COPD) as a disease of early aging: evidence from the EpiChron Cohort. PLoS One. 2018;13(2):e0193143.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Triest FJ, et al. Disease-specific comorbidity clusters in COPD and accelerated aging. J Clin Med. 2019;8(4):511.

    Article  CAS  PubMed Central  Google Scholar 

  19. Pauwels RA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.

    Article  CAS  PubMed  Google Scholar 

  20. Hansen JE, Sun X-G, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest. 2006;129(2):369–77.

    Article  PubMed  Google Scholar 

  21. Hardie J, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002;20(5):1117–22.

    Article  CAS  PubMed  Google Scholar 

  22. Swanney MP, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–51.

    Article  CAS  PubMed  Google Scholar 

  23. Schermer TR, et al. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J. 2008;32(4):945–52.

    Article  CAS  PubMed  Google Scholar 

  24. Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest. 2011;139(1):165–73.

    Article  PubMed  Google Scholar 

  25. Agusti A, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(2):347–60.

    Article  CAS  PubMed  Google Scholar 

  26. Divo M, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–61.

    Article  PubMed  Google Scholar 

  27. Paz-Díaz H, et al. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2007;86(1):30–6.

    Article  PubMed  Google Scholar 

  28. Spruit M, et al. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J. 2002;19(6):1072–8.

    Article  CAS  PubMed  Google Scholar 

  29. Majid H, Sharafkhaneh A. The pharmacotherapy of chronic obstructive pulmonary disease in the elderly: an update. Clin Med Insights Ther. 2011:3, CMT. S3408.

    Google Scholar 

  30. Grosser T, Smyth E, FitzGerald GA. Anti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of gout. In: Goodman and Gilman's the pharmacological basis of therapeutics, vol. 12; 2011. p. 959–1004.

    Google Scholar 

  31. Dolovich MB, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335–71.

    Article  PubMed  Google Scholar 

  32. Barrons R, Pegram A, Borries A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health Syst Pharm. 2011;68(13):1221–32.

    Article  CAS  PubMed  Google Scholar 

  33. Burrows B, et al. Characteristics of asthma among elderly adults in a sample of the general population. Chest. 1991;100(4):935–42.

    Article  CAS  PubMed  Google Scholar 

  34. Enright PL, et al. Underdiagnosis and undertreatment of asthma in the elderly. Chest. 1999;116(3):603–13.

    Article  CAS  PubMed  Google Scholar 

  35. Stupka E, deShazo R. Asthma in seniors: Part 1. Evidence for underdiagnosis, undertreatment, and increasing morbidity and mortality. Am J Med. 2009;122(1):6–11.

    Article  PubMed  Google Scholar 

  36. Hanania NA, et al. Asthma in the elderly: current understanding and future research needs—a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011;128(3):S4–S24.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Moorman JE. National surveillance for asthma–United States, 1980–2004; 2007.

    Google Scholar 

  38. Moorman JE, Moorman J, Mannino DM. Increasing US asthma mortality rates: who is really dying? J Asthma. 2001;38(1):65–71.

    Article  CAS  PubMed  Google Scholar 

  39. Bellia V, et al. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest. 2007;132(4):1175–82.

    Article  PubMed  Google Scholar 

  40. Banerjee D, et al. Underdiagnosis of asthma in the elderly. Br J Dis Chest. 1987;81:23–9.

    Article  CAS  PubMed  Google Scholar 

  41. Connolly M, et al. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax. 1992;47(6):410–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Bellia V, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest. 2003;123(4):1066–72.

    Article  PubMed  Google Scholar 

  43. Navaratnam P, et al. Asthma pharmacotherapy prescribing in the ambulatory population of the United States: evidence of nonadherence to national guidelines and implications for elderly people. J Am Geriatr Soc. 2008;56(7):1312–7.

    Article  PubMed  Google Scholar 

  44. Enríquez-Matas A, et al. Main contributory factors on asthma control and health-related quality of life (QoL) in elderly asthmatics. J Investig Allergol Clin Immunol. 2019;30

    Google Scholar 

  45. Badesch DB, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 Supplement):S55–66.

    Article  PubMed  Google Scholar 

  46. Federman AD, et al. Effect of a self-management support intervention on asthma outcomes in older adults: the SAMBA study randomized clinical trial. JAMA Intern Med. 2019;179(8):1113–21.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Milanese M, et al. Effects of a structured educational intervention in moderate-to-severe elderly asthmatic subjects. World Allergy Organ J. 2019;12(6):100040.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Galie N, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30(20):2493–537.

    Article  PubMed  Google Scholar 

  49. Rose JA, et al. Impact of age on pulmonary arterial hypertension studies. In: D25. Etiology and determinants of prognosis in pulmonary hypertension. American Thoracic Society; 2015. p. A5502.

    Google Scholar 

  50. Simonneau G, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Supplement):D34–41.

    Article  PubMed  Google Scholar 

  51. Ling Y, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med. 2012;186(8):790–6.

    Article  PubMed  Google Scholar 

  52. Ginoux M, et al. Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension. ERJ Open Res. 2018;4(4)

    Google Scholar 

  53. Lador F, Herve P. A practical approach of pulmonary hypertension in the elderly. In: Seminars in respiratory and critical care medicine. Thieme Medical Publishers; 2013.

    Google Scholar 

  54. Aguilaniu B, et al. European reference equations for CO and NO lung transfer. Eur Respir J. 2008;31(5):1091–7.

    Article  CAS  PubMed  Google Scholar 

  55. Mackay E, et al. Structural basis for the changing physical properties of human pulmonary vessels with age. Thorax. 1978;33(3):335–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Lettieri CJ, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129(3):746–52.

    Article  PubMed  Google Scholar 

  57. McGoon M, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(1):14S–34S.

    Article  PubMed  Google Scholar 

  58. Sitbon O, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111(23):3105–11.

    Article  CAS  PubMed  Google Scholar 

  59. Galiè N, et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013;62(25 Supplement):D60–72.

    Article  PubMed  Google Scholar 

  60. Galiè N, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–75.

    Article  CAS  PubMed  Google Scholar 

  61. Hoeper MM, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013;168(2):871–80.

    Article  PubMed  Google Scholar 

  62. Ginoux M, et al. Treatment of pulmonary arterial hypertension in elderly and very elderly patients. Eur Respiratory Soc; 2016.

    Book  Google Scholar 

  63. Hoyert DL, Kung H-C, Smith BL. Deaths: preliminary data for 2003. Natl Vital Stat Rep. 2005;53(15):1–48.

    PubMed  Google Scholar 

  64. Janssens J-P, Krause K-H. Pneumonia in the very old. Lancet Infect Dis. 2004;4(2):112–24.

    Article  PubMed  Google Scholar 

  65. Hoyert DL et al. Deaths: final data for 2003; 2006.

    Google Scholar 

  66. Krajcik S, Haniskova T, Mikus P. Pneumonia in older people. Rev Clin Gerontol. 2011;21(1):16.

    Article  Google Scholar 

  67. El-Solh AA, et al. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med. 2001;163(3):645–51.

    Article  CAS  PubMed  Google Scholar 

  68. Naucler P, et al. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia. Thorax. 2013;68(6):571–9.

    Article  PubMed  Google Scholar 

  69. Torres A, et al. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013;68(11):1057–65.

    Article  PubMed  Google Scholar 

  70. Farr B, et al. Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. Respir Med. 2000;94(5):422–7.

    Article  CAS  PubMed  Google Scholar 

  71. Sansoni P et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians [see comments]; 1993.

    Google Scholar 

  72. Toledo D, et al. Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions. BMJ Open. 2018;8(3)

    Google Scholar 

  73. Metlay JP, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997;157(13):1453–9.

    Article  CAS  PubMed  Google Scholar 

  74. Riquelme R, et al. Community-acquired pneumonia in the elderly: clinical and nutritional aspects. Am J Respir Crit Care Med. 1997;156(6):1908–14.

    Article  CAS  PubMed  Google Scholar 

  75. Cillóniz C, et al. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest. 2013;144(3):999–1007.

    Article  PubMed  Google Scholar 

  76. Metlay JP, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–67.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Kalil AC, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Raghu G, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Raghu G, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174(7):810–6.

    Article  PubMed  Google Scholar 

  80. Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Ann Rev Pathol. 2014;9:157–79.

    Article  CAS  Google Scholar 

  81. Baumgartner KB, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155(1):242–8.

    Article  CAS  PubMed  Google Scholar 

  82. Lee SH, et al. Association between occupational dust exposure and prognosis of idiopathic pulmonary fibrosis. Chest. 2015;147(2):465–74.

    Article  PubMed  Google Scholar 

  83. Kelly BG, et al. A rearranged form of Epstein–Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002;166(4):510–3.

    Article  PubMed  Google Scholar 

  84. Lawson WE, et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am J Phys Lung Cell Mol Phys. 2008;294(6):L1119–26.

    CAS  Google Scholar 

  85. Fell CD, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010;181(8):832–7.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Meyer KC, et al. Management of idiopathic pulmonary fibrosis in the elderly patient. Chest. 2015;148(1):242–52.

    Article  PubMed  Google Scholar 

  87. Raghu G. Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011. Eur Respiratory Soc; 2011.

    Google Scholar 

  88. Vaszar LT, et al. Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease. Respirology. 2018;23(5):507–11.

    Article  PubMed  Google Scholar 

  89. King TE Jr, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083–92.

    Article  PubMed  CAS  Google Scholar 

  90. Noble PW, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011;377(9779):1760–9.

    Article  CAS  PubMed  Google Scholar 

  91. Richeldi L, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–82.

    Article  CAS  PubMed  Google Scholar 

  92. Sakayori M, et al. Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis. Drug Des Dev Ther. 2019;13:2295.

    Article  CAS  Google Scholar 

  93. Sheth JS, et al. Frailty and geriatric conditions in older patients with idiopathic pulmonary fibrosis. Respir Med. 2019;148:6–12.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Nishiyama O, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13(3):394–9.

    Article  PubMed  Google Scholar 

  95. Pérez ERF, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest. 2010;137(1):129–37.

    Article  Google Scholar 

  96. Nathan SD, et al. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. Lancet Respir Med. 2017;5(1):33–41.

    Article  CAS  PubMed  Google Scholar 

  97. Smith BD, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758–65.

    Article  PubMed  Google Scholar 

  98. Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.

    Article  CAS  PubMed  Google Scholar 

  99. Ganti AK, et al. Treatment of non–small cell lung cancer in the older patient. J Natl Compr Cancer Netw. 2012;10(2):230–9.

    Article  CAS  Google Scholar 

  100. Muchnik E, et al. Immune checkpoint inhibitors in real-world treatment of older adults with non–small cell lung cancer. J Am Geriatr Soc. 2019;67(5):905–12.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Stuck AE, et al. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet. 1993;342(8878):1032–6.

    Article  CAS  PubMed  Google Scholar 

  102. Ruiz J, et al. Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. J Geriatr Oncol. 2019;10(1):48–54.

    Article  PubMed  Google Scholar 

  103. Fuchs L, et al. ICU admission characteristics and mortality rates among elderly and very elderly patients. Intensive Care Med. 2012;38(10):1654–61.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Fried LP, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Ser A Biol Med Sci. 2001;56(3):M146–57.

    Article  CAS  Google Scholar 

  105. Lin S-M, et al. The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med. 2004;32(11):2254–9.

    Article  CAS  PubMed  Google Scholar 

  106. McNicoll L, et al. Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc. 2003;51(5):591–8.

    Article  PubMed  Google Scholar 

  107. Thomason JW, et al. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care. 2005;9(4):R375.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Ely E, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27(12):1892–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Pisani MA, et al. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009;180(11):1092–7.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Pisani MA, et al. Benzodiazepine and opioid use and the duration of ICU delirium in an older population. Crit Care Med. 2009;37(1):177.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Fujii S, Tanimukai H, Kashiwagi Y. Comparison and analysis of delirium induced by histamine H2 receptor antagonists and proton pump inhibitors in cancer patients. Case Rep Ocol. 2012;5(2):409–12.

    Article  CAS  Google Scholar 

  112. Han L, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161(8):1099–105.

    Article  CAS  PubMed  Google Scholar 

  113. Pisani MA, Araujo KL, Murphy TE. Association of cumulative dose of haloperidol with next day delirium in older medical intensive care unit patients. Crit Care Med. 2015;43(5):996.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Van Rompaey B, et al. Risk factors for delirium in intensive care patients: a prospective cohort study. Crit Care. 2009;13(3):R77.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Freedman NS, et al. Abnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit. Am J Respir Crit Care Med. 2001;163(2):451–7.

    Article  CAS  PubMed  Google Scholar 

  116. Freedman NS, Kotzer N, Schwab RJ. Patient perception of sleep quality and etiology of sleep disruption in the intensive care unit. Am J Respir Crit Care Med. 1999;159(4):1155–62.

    Article  CAS  PubMed  Google Scholar 

  117. Weinhouse GL, et al. Bench-to-bedside review: delirium in ICU patients-importance of sleep deprivation. Crit Care. 2009;13(6):234.

    Article  PubMed  PubMed Central  Google Scholar 

  118. McCusker J, et al. Environmental risk factors for delirium in hospitalized older people. J Am Geriatr Soc. 2001;49(10):1327–34.

    Article  CAS  PubMed  Google Scholar 

  119. Pandharipande P, et al. Liberation and animation for ventilated ICU patients: the ABCDE bundle for the back-end of critical care. Crit Care. 2010;14(3):1–3.

    Article  Google Scholar 

  120. Ely EW, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med. 1996;335(25):1864–9.

    Article  CAS  PubMed  Google Scholar 

  121. Stites M. Observational pain scales in critically ill adults. Crit Care Nurse. 2013;33(3):68–78.

    Article  PubMed  Google Scholar 

  122. Ely EW, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983–91.

    Article  PubMed  Google Scholar 

  123. Ely EW, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703–10.

    Article  CAS  PubMed  Google Scholar 

  124. Burtin C, et al. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med. 2009;37(9):2499–505.

    Article  PubMed  Google Scholar 

  125. Balas MC, et al. Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility (ABCDE) bundle. Crit Care Med. 2014;42(5):1024.

    Article  PubMed  PubMed Central  Google Scholar 

  126. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23_suppl_1):I-4–8.

    Article  Google Scholar 

  127. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911–22.

    Article  PubMed  Google Scholar 

  128. Brochard L, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333(13):817–22.

    Article  CAS  PubMed  Google Scholar 

  129. Confalonieri M, et al. Noninvasive mechanical ventilation improves the immediate and long-term outcome of COPD patients with acute respiratory failure. Eur Respir J. 1996;9(3):422–30.

    Article  CAS  PubMed  Google Scholar 

  130. Evans TW. International Consensus Conferences in Intensive Care Medicine: non-invasive positive pressure ventilation in acute respiratory failure. Intensive Care Med. 2001;27(1):166–78.

    Article  CAS  PubMed  Google Scholar 

  131. Chandra D, et al. Patterns and outcomes of non-invasive positive-pressure ventilation for acute exacerbations of COPD in the US. In: C43. COPD: Mortality predictors, noninvasive positive-pressure ventilation, and more. American Thoracic Society; 2011. p. A4574.

    Chapter  Google Scholar 

  132. Kara I, et al. The impact of frailty on noninvasive mechanical ventilation in elderly medical intensive care unit patients. Aging Clin Exp Res. 2018;30(4):359–66.

    Article  PubMed  Google Scholar 

  133. Valley TS, et al. Association between noninvasive ventilation and mortality among older patients with pneumonia. Crit Care Med. 2017;45(3):e246.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Esteban A, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA. 2002;287(3):345–55.

    Article  PubMed  Google Scholar 

  135. Sudarsanam T, et al. Predictors of mortality in mechanically ventilated patients. Postgrad Med J. 2005;81(962):780–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Bauer TT, et al. Ventilator-associated pneumonia: incidence, risk factors, and microbiology. In: Seminars in respiratory infections; 2000.

    Google Scholar 

  137. Melsen WG, et al. Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies. Crit Care Med. 2011;39(12):2736–42.

    Article  PubMed  Google Scholar 

  138. Schneider GT, Christensen N, Doerr TD. Early tracheotomy in elderly patients results in less ventilator-associated pneumonia. Otolaryngol Head Neck Surg. 2009;140(2):250–5.

    Article  PubMed  Google Scholar 

  139. Perren A, et al. Protocol-directed weaning from mechanical ventilation: clinical outcome in patients randomized for a 30-min or 120-min trial with pressure support ventilation. Intensive Care Med. 2002;28(8):1058–63.

    Article  PubMed  Google Scholar 

  140. Jeganathan N, Kaplan CA, Balk RA. Ventilator liberation for high-risk-for-failure patients: improving value of the spontaneous breathing trial. Respir Care. 2015;60(2):290–6.

    Article  PubMed  Google Scholar 

  141. Anderson FA, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991;151(5):933–8.

    Article  PubMed  Google Scholar 

  142. Heit JA, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159(5):445–53.

    Article  CAS  PubMed  Google Scholar 

  143. Timmons S, et al. Pulmonary embolism: differences in presentation between older and younger patients. Age Ageing. 2003;32(6):601–5.

    Article  PubMed  Google Scholar 

  144. Schouten HJ, et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ. 2013;346:f2492.

    Article  PubMed  PubMed Central  Google Scholar 

  145. Righini M, et al. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med. 2000;109(5):357–61.

    Article  CAS  PubMed  Google Scholar 

  146. Cohen AT, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost. 2005;94(4):750.

    PubMed  Google Scholar 

  147. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993;95(3):315–28.

    Article  CAS  PubMed  Google Scholar 

  148. Levine MN, et al. Hemorrhagic complications of anticoagulant treatment. Chest. 2001;119(1):108S–21S.

    Article  CAS  PubMed  Google Scholar 

  149. White RH, et al. Major bleeding after hospitalization for deep-venous thrombosis. Am J Med. 1999;107(5):414–24.

    Article  CAS  PubMed  Google Scholar 

  150. Alikhan R, et al. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis. 2003;14(4):341–6.

    Article  CAS  PubMed  Google Scholar 

  151. Kucher N, et al. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial. Arch Intern Med. 2005;165(3):341–5.

    Article  CAS  PubMed  Google Scholar 

  152. Buchman TG, et al. Sepsis among medicare beneficiaries: 1. The Burdens of Sepsis, 2012–2018. Crit Care Med. 2020;48(3):276.

    Article  PubMed  PubMed Central  Google Scholar 

  153. Angus DC, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–10.

    Article  CAS  PubMed  Google Scholar 

  154. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34(1):15–21.

    Article  PubMed  Google Scholar 

  155. Bonomo RA. Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis. 2000;31(6):1414–22.

    Article  CAS  PubMed  Google Scholar 

  156. Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Supplement_7):S504–12.

    Article  CAS  PubMed  Google Scholar 

  157. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(1):5–13.

    Article  Google Scholar 

  158. Gleckman R, Hibert D. Afebrile bacteremia: a phenomenon in geriatric patients. JAMA. 1982;248(12):1478–81.

    Article  CAS  PubMed  Google Scholar 

  159. Iberti TJ, et al. Are the criteria used to determine sepsis applicable for patients< 75 years of age? Crit Care Med. 1993;21(4):S130.

    Article  Google Scholar 

  160. Martin-Loeches I, et al. Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study. Ann Intensive Care. 2019;9(1):26.

    Article  PubMed  PubMed Central  Google Scholar 

  161. El Solh AA, et al. Outcome of septic shock in older adults after implementation of the sepsis “bundle”. J Am Geriatr Soc. 2008;56(2):272–8.

    Article  PubMed  Google Scholar 

  162. Marik PE, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937–49.

    Article  CAS  PubMed  Google Scholar 

  163. Hébert PC, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340(6):409–17.

    Article  PubMed  Google Scholar 

  164. Wu W-C, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345(17):1230–6.

    Article  CAS  PubMed  Google Scholar 

  165. Walsh TS, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med. 2013;41(10):2354–63.

    Article  PubMed  Google Scholar 

  166. Gruber-Baldini AL, et al. Delirium outcomes in a randomized trial of blood transfusion thresholds in hospitalized older adults with hip fracture. J Am Geriatr Soc. 2013;61(8):1286–95.

    Article  PubMed  PubMed Central  Google Scholar 

  167. Wuerz RC, et al. Effect of age on prehospital cardiac resuscitation outcome. Am J Emerg Med. 1995;13(4):389–91.

    Article  CAS  PubMed  Google Scholar 

  168. Hayashi T, et al. Predictors associated with survival among elderly in-patients who receive cardiopulmonary resuscitation in Japan: an observational cohort study. J Gen Intern Med. 2019;34(2):206–10.

    Article  PubMed  Google Scholar 

  169. Ehlenbach WJ, et al. Epidemiologic study of in-hospital cardiopulmonary resuscitation in the elderly. N Engl J Med. 2009;361(1):22–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  170. van Gijn MS, et al. The chance of survival and the functional outcome after in-hospital cardiopulmonary resuscitation in older people: a systematic review. Age Ageing. 2014;43(4):456–63.

    Article  PubMed  Google Scholar 

  171. Detering KM, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340:c1345.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pulmonary, Critical Care, and Sleep Medicine Division, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA

    Derek A. Kruse & Kristina L. Bailey

Authors
  1. Derek A. Kruse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristina L. Bailey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristina L. Bailey .

Editor information

Editors and Affiliations

  1. Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA

    Andrew G. Lee

  2. Home Instead Center for Successful Aging, University of Nebraska Medical Center, Omaha, NE, USA

    Jane F. Potter

  3. San Francisco VA Health Care System, University of California, San Francisco, San Francisco, CA, USA

    G. Michael Harper

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kruse, D.A., Bailey, K.L. (2021). Pulmonary and Critical Care Medicine. In: Lee, A.G., Potter, J.F., Harper, G.M. (eds) Geriatrics for Specialists. Springer, Cham. https://doi.org/10.1007/978-3-030-76271-1_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-76271-1_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-76270-4

  • Online ISBN: 978-3-030-76271-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation